Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sabra REIT (SBRA)

Sabra REIT (SBRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Nursing Home REITs: The Surprise Heroes of High Yield Investing

Income seekers are finding value and yield in nursing home REITs Omega, Sabra and LTC Properties, as they offer stable dividends and tax benefits.

SBRA : 13.78 (+0.88%)
LTC : 32.12 (+0.60%)
OHI : 30.69 (+1.42%)
Sabra (SBRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and...

SBRA : 13.78 (+0.88%)
Sabra Healthcare (SBRA) Matches Q1 FFO Estimates

Sabra (SBRA) delivered FFO and revenue surprises of 0% and 1.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SBRA : 13.78 (+0.88%)
CLPR : 4.20 (-1.87%)
Sabra Reports First Quarter 2023 Results

Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2023.

SBRA : 13.78 (+0.88%)
Welltower (WELL) Q1 FFO and Revenues Beat Estimates

Welltower (WELL) delivered FFO and revenue surprises of 3.66% and 1.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

WELL : 92.93 (+1.44%)
SBRA : 13.78 (+0.88%)
Stag Industrial (STAG) Meets Q1 FFO Estimates

Stag (STAG) delivered FFO and revenue surprises of 0% and 1.96%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

STAG : 35.41 (+0.20%)
SBRA : 13.78 (+0.88%)
Sabra Health Care REIT, Inc. Announces First Quarter 2023 Earnings Release Date and Conference Call

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 first quarter earnings release on May 3, 2023, after the close of trading.

SBRA : 13.78 (+0.88%)
Implied Volatility Surging for Sabra Healthcare REIT (SBRA) Stock Options

Investors need to pay close attention to Sabra Healthcare REIT (SBRA) stock based on the movements in the options market lately.

SBRA : 13.78 (+0.88%)
This Dividend Stock Will Rise by 20%, Per Wall Street. Here's Why You Should Sell It.

Investors will likely be tempted by the high yield, but there's more to the story.

SBRA : 13.78 (+0.88%)
Beware Of These 2 High-Yield Dividend Stocks In 2023

Focus on the drivers that might cause a business to grow, not its dividend yield.

AFCG : 11.79 (-0.42%)
SBRA : 13.78 (+0.88%)

Barchart Exclusives

Should You Buy This Beaten-Down AI Stock for Its 4% Dividend Yield?
Sales of AI-enabled gadgets are expected to drive hardware sales over the next few years. PC maker HP looks like an AI play worth buying for its nearly 4% dividend yield and tepid valuations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar